Shine Technologies focuses on several key areas within the nuclear and radiation sectors, emphasizing the importance of safety, health, and sustainability. The company is involved in the production and sale of medical isotopes, specifically highlighting their product Ilumira, which includes lutetium-177, a critical isotope used in cancer treatment. Additionally, Shine Technologies conducts radiation effects testing through their FLARE service, which inspects industrial components to ensure they can withstand radiation exposure, thereby contributing to safer operational environments.

Moreover, Shine Technologies is committed to addressing environmental concerns through its recycling initiatives aimed at nuclear waste management. The company is also exploring the potential of fusion energy, positioning itself as a forward-thinking entity in the energy sector. By focusing on these areas—medical isotopes, radiation testing, waste recycling, and fusion energy—Shine Technologies aims to create a healthier and cleaner world while advancing the future of energy production.

United States

SHINE Technologies accelerates a practical, incremental four-phase pathway to clean, abundant fusion energy, starting with using fusion technology to solve today's problems in medicine, manufacturing, energy, and beyond. #SHINETogether #FusionTechnology

Shine Technologies

Company Details